![Roy F. Drucker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Roy F.
Drucker served as Director & Chief Medical Officer at Technomark Group USA LLC.
He also served as Chief Scientific Officer at Technomark Investment Management Ltd. from 2001 to 2008.
Anciens postes connus de Roy F. Drucker
| Sociétés | Poste | Fin |
|---|---|---|
Technomark Investment Management Ltd.
 Technomark Investment Management Ltd. Investment ManagersFinance TIM is an international venture capital investment manager following a hands-on approach with a long-term outlook. The firm invests in early-stage medical science companies throughout the UK and continental Europe, often with connections in Asia. They focus on sectors including drug development, outsourced R&D and manufacturing, medical devices, medical services, diagnostics and biotechnology. TIM's investment strategy consists in assessing the commercial potential of a given technology, and identifying or developing strong management teams. The firm sources deals through their extensive network in the pharmaceutical industry. They target projects in which they identify strong science with adequate IP protection, a clearly defined market with an achievable market share, a realistic technology development plan, and a strong management team. | Corporate Officer/Principal | 01/10/2008 |
Technomark Group USA LLC
 Technomark Group USA LLC Miscellaneous Commercial ServicesCommercial Services Provides life sciences facilities | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Technomark Investment Management Ltd.
Technomark Investment Management Ltd. Investment ManagersFinance TIM is an international venture capital investment manager following a hands-on approach with a long-term outlook. The firm invests in early-stage medical science companies throughout the UK and continental Europe, often with connections in Asia. They focus on sectors including drug development, outsourced R&D and manufacturing, medical devices, medical services, diagnostics and biotechnology. TIM's investment strategy consists in assessing the commercial potential of a given technology, and identifying or developing strong management teams. The firm sources deals through their extensive network in the pharmaceutical industry. They target projects in which they identify strong science with adequate IP protection, a clearly defined market with an achievable market share, a realistic technology development plan, and a strong management team. | Finance |
Technomark Group USA LLC
Technomark Group USA LLC Miscellaneous Commercial ServicesCommercial Services Provides life sciences facilities | Commercial Services |
